Shenzhen Readline Biotech Co., Ltd

Shenzhen Readline Biotech Co., Ltd. is an innovative bio-pharmaceutical high-tech enterprise with enzyme catalysis technology as its core (This technology has won the 2018 Nobel Prize in Chemistry) and multidisciplinary application. Readline Biotech is the first company to apply the directed evolution of enzymes to the all-green large-scale production of API such as peptides, carbohydrate and nucleic acids in the world. These API are mainly used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers and other fields

One-stop service provider for the peptide industry chain,peptide synthesis equipment,peptide purification equipment,peptide freeze-drying equipment,self-injection pen,peptide synthetic resin,polypeptide coupling reagent,peptide purification filler,peptide technology and registration services,peptide production line technical service,and project china market access service

Shenzhen readline biotech co., ltd operates in the Pharmaceutical manufacturing industry.

Shenzhen readline biotech co., ltd's revenue is 11m - 100m

Shenzhen readline biotech co., ltd has 11 - 50 employees.